Product Information

CELECOXIB 50 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0680 per EA under NDC 50228015660. Its NADAC has been published 254 times since Jan 12, 2022.

FDA first approved this application on Dec 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 50 MG CAPSULE

Celecoxib
$0.0680per EA

Strength

50 mg/1

NDC

50228015660

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA205129

FDA Approved

12/3/2020

TE Code

AB

On Market Since

12/3/2020

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 50 MG CAPSULE has been published 254 times since Jan 12, 2022, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0680 per EA
All-time high$0.2063 (Feb 16, 2022)
All-time low$0.0492 (Nov 20, 2024)
52-week high$0.1073
52-week low$0.0680
Median price$0.0996
Average price$0.1054
Largest weekly change+128.0% (Jan 19, 2022)
Weeks tracked254
Tracking sinceJan 12, 2022

Price History

1W

-16.3%

1M

-25.6%

3M

-23.0%

6M

-31.8%

1Y

-26.4%

3Y

-28.5%

5Y

N/A

All

-24.9%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CELECOXIB 50 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 50 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0680 per EA (NDC 50228015660), effective Nov 18, 2026.

How has the price of CELECOXIB 50 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 50 MG CAPSULE has declined 24.9%. It has been tracked across 254 weekly CMS publications since Jan 12, 2022.

What are the highest and lowest recorded NADAC prices for CELECOXIB 50 MG CAPSULE?

Since Jan 12, 2022, the NADAC for CELECOXIB 50 MG CAPSULE has ranged from a low of $0.0492 (Nov 20, 2024) to a high of $0.2063 (Feb 16, 2022), with a median of $0.0996 per EA.

Are there cheaper alternatives to CELECOXIB 50 MG CAPSULE?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CELECOXIB 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CELECOXIB 50 MG CAPSULE?

CELECOXIB 50 MG CAPSULE (NDC 50228015660) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.